Healthcare Jun 23, 2022 06:24 PM (GMT+8) · EqualOcean
Baiyunshan announced at the Hong Kong Stock Exchange on June 23 that considering the validity of the reply on approving Guangzhou Pharmaceutical Co., Ltd. to issue overseas listed foreign shares issued by the China Securities Regulatory Commission has expired on June 23, 2022, and the current environmental changes in the Hong Kong capital market, combined with the development planning of the company and Guangzhou Pharmaceutical, after careful study, the company and Guangzhou Pharmaceutical decided to temporarily suspend the proposed spin off, However, it is not excluded that the proposed spin off should be considered to be promoted again at an appropriate time according to the future market environment and business development needs.